Article thumbnail

Antidote Stocking at Hospitals in North Palestine

By Ansam Sawalha F, Waleed Sweileh M, Sa'ed Zyoud H and Samah Al-Jabi W


Objective: The purpose of this study was to determine the availability and adequacy of antidote stocking at hospitals in north Palestine based on published guidelines for antidote stocking. Methodology: This study is a cross sectional survey of all hospitals at north Palestine (n=11) using a questionnaire which was completed by the director of the pharmacy department at each hospital. The questionnaire was divided into 2 parts. The first part contained a list of 25 antidotes while the second part contained a list of 12 antidotes. This classification is based on the guideline proposed by the British Association for Emergency Medicine (BAEM). The net antidote stock results were compared with the American guidelines as well. Result: The overall availability of each antidote in the first list varied widely from zero for glucagon to 100% for atropine. The number antidotes of the first list that were stocked in the 11 hospitals ranged from 5 to 12 antidotes but none of the hospitals stocked all the 25 antidotes. Additionally, availability of antidotes in the second list varied widely from zero for polyethylene glycol to 100% for dobutamine. The number of antidotes stocked ranged from 5 to 9 but none of the hospitals stocked all the 12 antidotes. Discussion and Conclusion: hospitals in north Palestine do not have adequate stock of antidotes. Raising awareness of the importance of antidotes by education, regular review of antidote storage, distribution plans, and appropriate legislation might provide solutions. Coordination between Palestinian hospitals and the PCDIC at An-Najah National University is also important

Topics: Online Journal of Health and Allied Sciences
Publisher: Dr. B.S. Kakkilaya
Year: 2007
OAI identifier:

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1995). Annual report of the American Association of Poison Control Centers toxic exposure surveillance system.
  2. Antidote availability in Norway. Tidsskr Nor Laegeforen.
  3. Antidote availability in Quebec hospital pharmacies: impact of N-acetylcysteine and naloxone consumption.
  4. Antidote use in the critically ill poisoned patient.
  5. Availability of antidotes in acute care hospitals in Ontario.
  6. Availability of antidotes in hospital pharmacies in the Czech Republic. Ceska Slov Farm.
  7. (1994). Availability of antidotes in rural and urban hospitals in Tennessee.
  8. Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States. Ann Emerg Med.
  9. Drugand chemical-induced methaemoglobinemia: Clinical features and management.
  10. Evaluation of antidotes: Activities of the international programme on chemical safety.
  11. Guideline on antidote availability for accident and emergency department: Guy’s and St Thomas’ poison unit, Royal College of surgeons of England, British association for emergency medicine.
  12. (1997). Krenzelok EP. Clinical Applications of commonly used contemporary antidotes: A US perspective. Drug Safety
  13. Lowenstein SR Insufficient stocking of poison antidotes in hospital pharmacies.
  14. Nonavailability of poison antidotes [letter].
  15. On-site availability of selected antidotes: results of a survey of Massachusetts hospitals.
  16. (1991). Pattern of acute intoxication in Florence: A comparative investigation. Intensive Care Med.
  17. Problems in hospital preparation of acute poisoning antagonist (methylene blue injection) Chudoku Kenkyu.
  18. Survey of the stocking of poison antidotes in Alabama hospitals.
  19. Taiwan National Poison Center: Epidemiologic data 1985–1993.
  20. (1997). The WHO Expert Committee The use of essential drugs. Model List of Essential Drugs (ninth list).